To include your compound in the COVID-19 Resource Center, submit it here.

Exenatide meets tQT study endpoint

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN), Eli Lilly and Co. (NYSE:LLY) and Alkermes Inc. (NASDAQ:ALKS) plan to respond this quarter to FDA's

Read the full 209 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE